|Articles|May 8, 2020

What we expected from the most recent pandemic relief bill

Anders Gilberg, senior vice president of government affairs for MGMA, speaks April 21 about what was expected in the COVID-19 coronavirus pandemic relief bill that was passed by the U.S. Senate later that day.

Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.

Subscribe Now!

Latest CME

Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Video

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Trending on Medical Economics

FTC: Express Scripts settlement signals major shift in insulin pricing, PBM oversight, pharmacy transparency

Federal spending plan: Follow the money to find winners in health care

Affordable drug advocates claim victory over pharmacy benefit managers in budget bill

Workplace violence is a business risk: CENTEGIX’s Andrea Greco on safety and staffing in health care

Brooklyn banker guilty in $8M transnational Medicare fraud; new blood test may spot pancreatic cancer earlier; NIH opens Ohio office to study train derailment health effects – Morning Medical Update

What we expected from the most recent pandemic relief bill

Newsletter

Related Content

2026 payment processing trends you need to know

Policy uncertainty in 2026, with Anders Gilberg of MGMA

Mindfulness in medicine: Why just a moment can make a difference

Building trust with patients using virtual care

Osteopathic medical education: High touch integrates high tech